Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

64
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
64
Cancer02:18

Cancer

47.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.4K
Longitudinal Research02:20

Longitudinal Research

11.8K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyยท2026
Same author

Web questionnaire survey of physicians and patients on the side effects of trifluridine/tipiracil.

Scientific reportsยท2026
Same author

Research Survey on Recognition of Medical Oncology among Medical Students and Junior Residents in Japan.

Journal of cancer education : the official journal of the American Association for Cancer Educationยท2026
Same author

Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyยท2026
Same author

Metabolic and functional pathways of gut microbiota in patients with gastric cancer.

Scientific reportsยท2026
Same author

Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trial.

Esophagus : official journal of the Japan Esophageal Societyยท2025

Related Experiment Video

Updated: May 8, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

2.9K

[Human Resources Development in Cancer Research].

Takako Eguchi Nakajima1

  • 1Dept. of Early Clinical Development, Kyoto University Graduate School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|December 25, 2024
PubMed
Summary

Addressing human resources development in cancer research requires a multifaceted approach. Key issues include physician-scientist training, grant funding, work-life balance, and promoting women in leadership roles to foster innovation and solve complex health challenges.

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.2K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.8K

Related Experiment Videos

Last Updated: May 8, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

2.9K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.2K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.8K

Area of Science:

  • Oncology
  • Medical Research
  • Human Resources Development

Context:

  • Challenges in developing human resources for cancer research are multifaceted.
  • Current systems present barriers for early-career researchers and established professionals alike.

Purpose:

  • To identify and address critical issues in human resources development within the cancer research field.
  • To propose comprehensive strategies for nurturing a robust and diverse research workforce.

Summary:

  • Key areas for improvement include establishing a board certification platform, optimizing graduate medical education and international research opportunities for young scientists.
  • Addressing grant funding (Kakenhi) reduction, implementing work system reforms for physicians, and promoting women researchers to managerial positions are crucial.

Impact:

  • Enhancing the cancer research workforce through strategic human resource development will accelerate scientific discovery.
  • Fostering interdisciplinary networking and career expansion will enable researchers to tackle complex societal health issues effectively.